CHIMERIC THERAPEUTICS LIMITED (CHM)

---

AI Coverage Rating: High

ASX AI Signals has generated 6 signals for CHM during the last 90 days, indicating strong trading activity and ongoing AI monitoring

Latest CHM Signals
02/07/2026	SELL
21/04/2026	BUY
17/04/2026	SELL
CHM Share Price
Current Price	$0.058
52 Week High	$0.210
52 Week Low:	$0.001
Trading at (% of 52 Week High)	27.62%

Business Overview

Chimeric Therapeutics Limited (ASX: CHM) is a biotechnology company focused on developing advanced cell therapies for cancer treatment. The company specializes in chimeric antigen receptor (CAR) natural killer (NK) cell therapies aimed at improving outcomes for patients with blood cancers.

ASX Sector Overview

Sector:  

Latest AI Recommendation

The SELL recommendation for CHIMERIC THERAPEUTICS LIMITED is supported by weak price performance and potential sector volatility. However, the relatively low stock price and possible speculative interest introduce moderate uncertainty.

Latest  CHIMERIC THERAPEUTICS LIMITED(CHM)   News

21 Jun 2022, 10:00 PM

Diamond Equity Research to Host Emerging Growth Invitational Virtual Investor Conference on June 23, 2022

Presenting Companies to Host 25 Minute Presentations Followed by Question-and-Answer Session; Conference Open to all Retail and Institutional Investors NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will h

16 Nov 2021, 01:00 AM

Diamond Equity Research Emerging Growth Invitational Winter 2021 Spotlight Virtual Conference

30 Minute presenting time slots from 9am to 1pm EST November 16, 2021 Presentation times and links distributed for all presenting companies Investors will be provided time after presentation to ask questions Welcome all institutional and retail investors NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) --